Average Co-Inventor Count = 1.50
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aventis Pharma S.a. (8 from 377 patents)
2. Other (1 from 832,961 patents)
3. Aventis Pharmaceuticals Inc. (1 from 207 patents)
4. Aventia Pharma S.a. (1 from 1 patent)
11 patents:
1. 7538106 - Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament
2. 6982262 - Combination of cyamemazine and an atypical neuroleptic
3. 6720318 - Combination of cyamemazine and an atypical neuroleptic
4. 6713493 - Use of nicergoline in the treatment of spasticity
5. 6642262 - Riluzole and alpha-tocopherol combination
6. 6469019 - Therapeutic application of nicergoline
7. 6451818 - Therapeutic use of 1,6-dimethyl-8&bgr;-hydroxymethyl-10&agr;-methoxyergoline
8. 6432992 - Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy
9. 6380208 - Use of nicergoline for treating spasticity
10. 6339095 - Therapeutic use of 1, 6-dimethyl-8&bgr;-hydroxymethyl-10-&agr;-methoxyergoline
11. 6297254 - Method for the prevention or treatment of a motoneuron disease